Previous Article | Next Article ![]()
J Virol, February 1998, p. 1203-1209, Vol. 72, No. 2
Laboratory of Viral Diseases, National
Institutes of Health, Bethesda, Maryland 20892,1
and
Department of Microbiology, Arizona State University,
Tempe, Arizona 852872
Received 9 June 1997/Accepted 28 October 1997
R13-1 is an intertypic recombinant virus in which the left-hand
18% of the herpes simplex virus type 1 (HSV-1) genome is replaced by
homologous sequences from HSV-2. R13-1 is nonneurovirulent and
defective in DNA replication in neurons. The defect was localized to
the UL5 open reading frame by using marker rescue analysis (D. C. Bloom and J. G. Stevens, J. Virol. 68:3761-3772,
1994). To provide conclusive evidence that UL5 is the only HSV-2 gene involved in the restricted replication phenotype of R13-1, we have
characterized the phenotype of a recombinant virus (IB1) in which only
the UL5 gene of HSV-1 was replaced by HSV-2 UL5. Data from 50% lethal
dose determinations and the in vivo yields of virus suggested that IB1
has the same phenotypic characteristics as R13-1. UL5 is the helicase
component of a complex with helicase and primase activities. All three
subunits of this complex (UL5, UL8, and UL52) are required for viral
DNA replication in all cell types. The intertypic complex HSV-2
UL5-HSV-1 UL8-HSV-1 UL52 was purified and biochemically
characterized. The primase activity of the intertypic complex was
10-fold lower than that of HSV-1 UL5-HSV-1 UL8-HSV-1 UL52. The ATPase
activity was comparable to that of the HSV-1 enzyme complex, and
although the helicase activity was threefold lower, this did not
interfere with the synthesis of leading strands by the HSV polymerase.
One explanation for these findings is that the interactions between the
subunits of the helicase-primase intertypic complex that are important
for the full function of each subunit are inappropriate or weak.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
An Intertypic Herpes Simplex Virus Helicase-Primase
Complex Associated with a Defect in Neurovirulence Has Reduced
Primase Activity
*
Corresponding author. Mailing address: Laboratory of
Viral Diseases, National Institutes of Health, 9000 Rockville Pike,
Bethesda, MD 20892. Phone: (301) 496-8274. Fax: (301) 402-2622. E-mail: mchallberg{at}atlas.niaid.nih.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»